Key result
Every 1 standard deviation increase in natural-log transformed urinary angiotensinogen and MCP-1 excretion was associated with elevated blood pressure in obese young male adults.
Why the study?
Is urinary angiotensinogen excretion associated with elevated blood pressure in obese young adults?
Cross-Sectional (n=111)
Is urinary angiotensinogen excretion associated with elevated blood pressure in obese young adults?
Urinary angiotensinogen and MCP-1 excretion are associated with elevated blood pressure in obese young men, suggesting they could serve as early screening markers for hypertension.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for urinary biomarkers in obese young men; does not support practice change pending prospective data.
Intrarenal RAS has been suggested to be involved in the pathogenesis of hypertension. It was recently reported that urinary angiotensinogen excretion levels are associated with intrarenal RAS. However, few markers predicting intrarenal RAS have been investigated in obese young subjects. The present study evaluated the association between blood pressure and intrarenal RAS activity, inflammation and oxidative stress in obese young adults. Urinary angiotensinogen excretion and urinary monocyte chemotactic protein (MCP)-1, and urinary thiobarbituric acid reaction substance (TBARS) as markers of intrarenal RAS activity, inflammation, and oxidative stress, respectively, were determined from morning urine of 111 young male adults. Participants were divided into two groups based on the body mass index (BMI). Natural log-transformed urinary angiotensinogen excretion level was significantly associated with blood pressure, MCP-1 excretion, and TBARS excretion elevation in the obese group (BMI ≥25 kg/m(2)). Multivariable analyses showed that every 1 standard deviation increase in natural-log transformed urinary angiotensinogen and MCP-1 excretion, but not TBARS excretion level was associated with elevated blood pressure in the obese group. These results indicate that urinary angiotensinogen and MCP-1 excretion were associated with blood pressure elevation in this population of obese young adults. It suggested that inappropriate RAS activity and inflammation precedes hypertension in obese young subjects and urinary angiotensinogen could be a screening maker for hypertension in young obese subjects.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2016) conducted a cross-sectional in Obesity and hypertension (n=111). Urinary angiotensinogen and MCP-1 excretion was evaluated on Blood pressure elevation. Every 1 standard deviation increase in natural-log transformed urinary angiotensinogen and MCP-1 excretion was associated with elevated blood pressure in obese young male adults.
Synapse has enriched 10 related papers. Consider them for comparative context: